Optic Neuritis Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight

1. Optic Neuritis Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight (Albany, US) DelveInsight has launched a new report on "Optic Neuritis - Market Insights, Epidemiology, and Market Forecast-2030". DelveInsight's "Optic Neuritis - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Optic Neuritis, historical and forecasted epidemiology as well as the Optic Neuritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some of the facts: A rare condition with an estimated annual incidence of 6.4 per 100,000 cases in population in the United States. ON is most common among adults, age 20 to 40 years, and its symptoms generally improve in 80 percent of patients over few weeks. More females are affected than males and approximately five out of every one-hundred thousand people are affected by ON every year View Report: https://www.delveinsight.com/report-store/optic-neuritis-market Request for free sample report: https://www.delveinsight.com/sample-request/optic-neuritis- market Scope of the Report  The report covers the descriptive overview of Optic Neuritis, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies  Comprehensive insight has been provided into the Optic Neuritis epidemiology and treatment in the 7MM  Additionally, an all-inclusive account of both the current and emerging therapies for Optic Neuritis are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape  A detailed review of Optic Neuritis market; historical and forecasted is included in the report, covering drug outreach in the 7MM  The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Optic Neuritis market Optic Neuritis (ON) is the swelling of the eye’s optic nerve. The optic nerve carries light signals from the back of the eye to the brain so that a person can see. A person cannot see clearly if the optic nerve is swollen, damaged or is infected.

2. It is an acute rare disorder which usually occurs in one eye, and is being characterized by the symptoms including blurring of vision, a loss of part or all of central vision, reduced color vision, and dimness of vision. Most patients with ON have eye pain which characteristically worsen with movement of the eye. View Report: https://www.delveinsight.com/report-store/optic-neuritis-market Request for free sample report: https://www.delveinsight.com/sample-request/optic-neuritis- market Some of the companies covered: Biogen Mitochon Pharmaceuticals Noveome Biotherapeutics And Many Others Drugs Covered: Opicinumab MP101 ST266 And Many Others View Report: https://www.delveinsight.com/report-store/optic-neuritis-market Request for free sample report: https://www.delveinsight.com/sample-request/optic-neuritis- market Table of Contents: 1. Key Insights 2. Executive Summary of Optic Neuritis 3. Competitive Intelligence Analysis for Optic Neuritis 4. Optic Neuritis: Market Overview at a Glance 4.1. Optic Neuritis Total Market Share (%) Distribution in 2017 4.2. Optic Neuritis Total Market Share (%) Distribution in 2030 5. Optic Neuritis: Disease Background and Overview 5.1. Introduction 5.2. Sign and Symptoms 5.3. Pathophysiology 5.4. Risk Factors 5.5. Diagnosis 6. Patient Journey

3. 7. Optic Neuritis Epidemiology and Patient Population 7.1. Epidemiology Key Findings 7.2. Assumptions and Rationale: 7MM 7.3. Epidemiology Scenario: 7MM 7.3.1. Optic Neuritis Epidemiology Scenario in the 7MM (2017-2030) 7.4. United States Epidemiology 7.4.1. Optic Neuritis Epidemiology Scenario in the United States (2017-2030) 7.5. EU-5 Country-wise Epidemiology 7.5.1. Germany Epidemiology 7.5.1.1. Optic Neuritis Epidemiology Scenario in Germany (2017-2030) 7.5.2. France Epidemiology 7.5.2.1. Optic Neuritis Epidemiology Scenario in France (2017-2030) 7.5.3. Italy Epidemiology 7.5.3.1. Optic Neuritis Epidemiology Scenario in Italy (2017-2030) 7.5.4. Spain Epidemiology 7.5.4.1. Optic Neuritis Epidemiology Scenario in Spain (2017-2030) 7.5.5. United Kingdom Epidemiology 7.5.5.1. Optic Neuritis Epidemiology Scenario in the United Kingdom (2017-2030) 7.5.6. Japan Epidemiology 7.5.6.1. Optic Neuritis Epidemiology Scenario in Japan (2017-2030) 8. Treatment Algorithm, Current Treatment, and Medical Practices 8.1. Optic Neuritis Treatment and Management 8.2. Optic Neuritis Treatment Algorithm 9. Unmet Needs 10. Key Endpoints of Optic Neuritis Treatment 11. Marketed Products 11.1. List of Marketed Products in the 7MM 11.2. Drug Name: Company Name 11.2.1. Product Description 11.2.2. Regulatory Milestones 11.2.3. Other Developmental Activities

4. 11.2.4. Pivotal Clinical Trials 11.2.5. Summary of Pivotal Clinical Trial List to be continued in report 12. Emerging Therapies 12.1. Key Cross 12.2. Drug Name: Company Name 12.2.1. Product Description 12.2.2. Other Developmental Activities 12.2.3. Clinical Development 12.2.4. Safety and Efficacy 12.2.5. Product Profile List to be continued in report 13. Optic Neuritis: Seven Major Market Analysis 13.1. Key Findings 13.2. Optic Neuritis Market Size in 7MM 13.3. Optic Neuritis Market Size by Therapies in the 7MM 14. Attribute analysis 15. 7MM: Market Outlook 15.1. United States: Market Size 15.1.1. Optic Neuritis Total Market Size in the United States 15.1.2. Optic Neuritis Market Size by Therapies in the United States 15.2. EU-5 countries: Market Size and Outlook 15.3. Germany Market Size 15.3.1. Optic Neuritis Total Market Size in Germany 15.3.2. Optic Neuritis Market Size by Therapies in Germany 15.4. France Market Size 15.4.1. Optic Neuritis Total Market Size in France 15.4.2. Optic Neuritis Market Size by Therapies in France 15.5. Italy Market Size 15.5.1. Optic Neuritis Total Market Size in Italy 15.5.2. Optic Neuritis Market Size by Therapies in Italy

5. 15.6. Spain Market Size 15.6.1. Optic Neuritis Total Market Size in Spain 15.6.2. Optic Neuritis Market Size by Therapies in Spain 15.7. United Kingdom Market Size 15.7.1. Optic Neuritis Total Market Size in the United Kingdom 15.7.2. Optic Neuritis Market Size by Therapies in the United Kingdom 15.8. Japan Market Outlook 15.8.1. Japan Market Size 15.8.2. Optic Neuritis Total Market Size in Japan 15.8.3. Optic Neuritis Market Size by Therapies in Japan 16. Access and Reimbursement Overview of Optic Neuritis 17. KOL Views 18. Market Drivers 19. Market Barriers 20. Appendix 20.1. Bibliography 20.2. Report Methodology 21. DelveInsight Capabilities 22. Disclaimer 23. About DelveInsight View Report: https://www.delveinsight.com/report-store/optic-neuritis-market Request for free sample report: https://www.delveinsight.com/sample-request/optic-neuritis- market About DelveInsight DelveInsight is a premier Business Consulting and Market Research firm focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions for Browse through our vast repository from here. Media Contact Company Name: DelveInsight Business Research LLP Contact Person: Ankit Nigam Email: info@delveinsight.com Phone: +19193216187 City: Albany

6. State: New York Country: United States Website: https://www.delveinsight.com/